GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Marketable Securities

Nyxoah (XBRU:NYXH) Marketable Securities : €22.23 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Nyxoah's Marketable Securities for the quarter that ended in Mar. 2024 was €22.23 Mil.

Nyxoah's annual Marketable Securities increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€76.97 Mil) but then declined from Dec. 2022 (€76.97 Mil) to Dec. 2023 (€36.14 Mil).


Nyxoah Marketable Securities Historical Data

The historical data trend for Nyxoah's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Marketable Securities Chart

Nyxoah Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial - - - 76.97 36.14

Nyxoah Quarterly Data
Dec17 Dec18 Jun19 Dec19 Mar20 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.40 67.92 59.24 36.14 22.23

Nyxoah Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Nyxoah  (XBRU:NYXH) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Nyxoah Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nyxoah's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nyxoah (XBRU:NYXH) Business Description

Traded in Other Exchanges
Address
Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.